Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

HLA-DR Antikörper (FITC)

HLA-DR Reaktivität: Human, Affe FACS Wirt: Maus Monoclonal 423L FITC

Produktnummer ABIN264299

Datenblatt (PDF)

Target Alle HLA-DR Produkte

HLA-DR
Reaktivität
140

22

21

20

20

14

11

8

5

4

3

3

2

1
Human, Affe
Wirt
121

13

10
Maus
Passende Sekundärantikörper
Klonalität
137

6
Monoklonal
Konjugat
48

16

16

11

10

5

4

3

3

3

3

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser HLA-DR Antikörper ist konjugiert mit FITC
Applikation
123

35

26

24

17

13

12

10

7

6

5

3

3

2

2

2

1

1

1

1

1

1

1

1
Flow Cytometry (FACS)

Produktmerkmale

Synonyms: HLA-DR, HLA class II histocompatibility antigen DR, MHC class II antigen DR

Klon

423L

Isotyp

IgG2a
anti-HLA-DR (HLA-DR) antibody (FITC)
HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 FITC

anti-HLA-DR (HLA-DR) antibody
HLA-DR Reaktivität: Human FACS, WB, IHC, ISt, StM Wirt: Maus Monoclonal TAL 1B5 unconjugated

anti-HLA-DR (HLA-DR) antibody
HLA-DR Reaktivität: Human FACS, WB, IP Wirt: Maus Monoclonal MEM-12 unconjugated

anti-HLA-DR (HLA-DR) antibody
HLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC Wirt: Maus Monoclonal L243 unconjugated

anti-HLA-DR (HLA-DR) antibody (PE)
HLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS Wirt: Maus Monoclonal L243 PE

anti-HLA-DR (HLA-DR) antibody
HLA-DR Reaktivität: Human FACS, WB, IHC, IF, ISt, StM Wirt: Maus Monoclonal SPM289 unconjugated

anti-HLA-DR (HLA-DR) antibody
HLA-DR Reaktivität: Human FACS, IP Wirt: Maus Monoclonal HL-39 unconjugated

anti-HLA-DR (HLA-DR) antibody
HLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC, Func Wirt: Maus Monoclonal L243 unconjugated

anti-HLA-DR (HLA-DR) antibody (PerCP)
HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 PerCP

anti-HLA-DR (HLA-DR) antibody (APC)
HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 APC

Applikationshinweise

Flow Cytometry. Monitoring of B cells in peripheral blood. Analysis of B subsets. Study of B cell activation. Study of B cell neoplasms.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Protokoll

PBMC: Add 10 ul of MAB/10e6 PBMC in 100 ul PBS. Mix gently and incubate for 15 minutes at 2-8°C. Wash twice with PBS and analyze or fix with 0. 5% v/v of paraformaldehyde in PBS andanalyze. WHOLE BLOOD: Add 10 ul of MAB/100 ul of whole blood. Mix gently and incubate for 15 minutes at room temperature (20°C). Lyse the whole blood. Wash once with PBS and analyze or fix with 0. 5% v/v of paraformaldehyde in PBS andanalyze. See instrument manufacturers instructions for Lysed Whole Blood andImmunofluorescence analysis with a flow cytometer or microscope.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Buffer

PBS containing 0.2 % protein carrier and 0.08 % Sodium Azide as preservative.

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung

4 °C

Informationen zur Lagerung

Store the antibody undiluted at 2-8 °C. Do Not Freeze!
Shelf life: One year from despatch.

Haltbarkeit

12 months
Target

HLA-DR

Andere Bezeichnung

HLA Class II DR (HLA-DR Produkte)

Hintergrund

Identification of human B cell and T cell subsets associated with approximately 10 % of peripheral blood lymphocytes 28-34,000 M.W. surface antigen, also low density on monocytes and macrophages.Synonyms: HLA class II histocompatibility antigen DR, HLA-DR, MHC class II antigen DR

Pathways

Human Leukocyte Antigen (HLA) in Adaptive Immune Response